glypican 3
| GO Term | Evidence Code | PMID |
|---|---|---|
| positive regulation of protein catabolic process | ||
| positive regulation of endocytosis | ||
| negative regulation of smoothened signaling pathway | ||
| positive regulation of smoothened signaling pathway | ||
| negative regulation of growth |
| GO Term | Evidence Code | PMID |
|---|---|---|
| endoplasmic reticulum lumen | ||
| Golgi lumen | ||
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane |
| GO Term | Evidence Code | PMID |
|---|---|---|
| protein binding | ||
| peptidyl-dipeptidase inhibitor activity |
| Gene Ontology |
|---|
| cell migration |
| regulation of protein localization to membrane |
| InterPro |
|---|
| Glypican |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0060248 | Simpson-Golabi-Behmel syndrome type 1 | |
| DOID:2154 | nephroblastoma |
| HPO ID | HPO Term |
|---|---|
| HP:0001442 | Typified by somatic mosaicism |
| HP:0001522 | Death in infancy |
| HP:0001537 | Umbilical hernia |
| HP:0001539 | Omphalocele |
| HP:0001540 | Diastasis recti |
| HP:0001548 | Overgrowth |
| HP:0001561 | Polyhydramnios |
| HP:0001608 | Abnormality of the voice |
| HP:0001609 | Hoarse voice |
| HP:0001629 | Ventricular septal defect |
| Disease ID | Disease Name |
|---|---|
| OMIM:312870 |
|
| ORPHA:654 |
|
| OMIM:194070 |
|
| ORPHA:373 |
|
| Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
|---|---|---|---|
| 100084108 | ORNAN23402 | ||
| 100219859 | TAEGU23005 | ||
| 100351858 | RABIT13904 | ||
| 100401118 | CALJA47550 | ||
| 100444952 | PONAB37440 | ||
| 100477314 | AILME13264 | ||
| 100591673 | NOMLE38673 | ||
| 100726246 | CAVPO23090 | ||
| 100768919 | CRIGR10771 | ||
| 100981056 | PANPA42122 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025